Milk production, plasma bovine somatotropin (bST) and insulin-like growth factor I (IGF-1) were measured in dairy cows following a single subcutaneous injection of a slowly released preparation of either recombinant enterokinase linker bST (somidobove: 640 mg) or recombinant methionyl bST (sometribove: 500 mg). There was a 3-7-fold increase in plasma bST concentrations during the first three postinjection hours in cows treated with both sometribove (from 3.4±0.8 to 11.2±3.0 ng ml-1) or somidobove (from 2.3±0.3 to 17.5±2.6 ng ml-1). In the next 8 days the bST concentration in the bST-treated cows varied, but was still significantly increased above the controls. In the following days, the concentrations of bST did not differ from the controls. Plasma concentrations of IGF-1 increased nearly 2-fold as early as 24 h following recombinant bST administration and then continued to rise so that by 48 h postinjection they were nearly four times higher (control 16.2, bST-treated 61.7 ng ml-1). From 48 h after sometribove injection, IGF-1 concentrations remained at a plateau (varying between 60.4 and 85.7 ng ml-1) till day 11. Then it decreased slowly, but still remained higher on day 14 than those in placebo-treated cows (44.4±17.8 ng ml-1 in bST-treated animals; 12.2±7.5 ng ml-1 in the controls). Although IGF-1 level was increasing in all bST-treated animals, the absolute IGF-1 increase was not related to the increase in milk production.
Hepcidin is a key regulator of iron metabolism and a mediator of anemia in inflammation. Recent in vitro studies recognized prohepcidin as a type II acute phase protein regulating via interleukin-6. The aim of the present study was to investigate the time course of plasma prohepcidin after a large cardiac surgery in relation to IL-6 and other inflam matory parameters. Patients with chronic thromboembolic hypertension (n=22, males/females 14/8, age 51.9±10.2 years) underwent pulmonary endarterectomy using cardiopulmonary bypass and deep hypothermic circulatory arrest were included into study. Arterial concentrations of prohepcidin, IL-1β , IL-6, IL-8, tumor necrosis factor-α , and C-reactive protein were measured before/after sternotomy, after circulatory arrest, after separation from bypass, and then 12, 18, 24, 36, 48 h and 72 h after the separation from bypass. Hemodynamic parameters, hematocrit and markers of iron metabolism were followed up. Pulmonary endarterectomy induced a 48 % fall in plasma prohepcidin; minimal concentrations were detected after separation from cardiopulmonary bypass. Prohepcidin decline correlated with an extracorporeal circulation time (p<0.01), while elevated IL-6 levels were inversely associated with duration of prohepcidin decline. Postoperative prohepcidin did not correlate with markers of iron metabolism or hemoglobin concentrations within a 72-h period after separation from CPB. Prohepcidin showed itself as a negative acute phase reactant during systemic inflammatory response syndrome associated with a cardiac surgery. Results indicate that the evolution of prohepcidin in postoperative period implies the antagonism of stimulatory effect of IL-6 and contraregulatory factors inhibiting prohepcidin synthesis or increasing prohepcidin clearance., P. Maruna ... [et al.]., and Obsahuje seznam literatury
Tissue factor is a cell surface protein that is expressed constitutively by monocytes, macrophages and fibroblasts, but also by some other cells in response to a variety of stimuli. The main function of the tissue factor is to form a complex with factor VII/VIIa that converts factors IX and X to their active forms. Tissue factor is also involved in the pathophysiology of systemic inflammatory disorders, coagulopathies, atherosclerotic disease, tumor angiogenesis and metastasis. Increased tissue factor expression either locally in the coronary plaques or systematically on circulating blood elements of patients with acute coronary syndromes may be responsible for increased thrombin generation, thus leading to platelet activation and fibrin formation. Tissue factor therefore plays a pivotal role in the initiation of thrombotic complications in patients with coronary artery disease., J. Vojáček, J. Dušek, J. Bis, J. Šťásek, M. Blažek., and Obsahuje bibliografii a bibliografické odkazy
The possible association of plasma lipids (triglycerides and cholesterol) with erythrocyte Na+ content (Na+j) and/or with alterations in red cell Na+ and K+ (Rb+) transport was studied in a population of F2 hybrids obtained by crossing hypertensive Prague hereditary hypertriglyceridaemic (HTG) rats with normotensive Lewis rats. The obtained data indicated a strong cosegregation (p<0.001) of plasma triglycerides with erythrocyte Na+ content. This was the cause for the close correlation of plasma triglycerides with the Ma+-K+ pump activity (measured as ouabain-sensitive Na+ extrusion). On the contrary, there was only marginal association (p<0.05) of erythrocyte Na+ content with plasma cholesterol which was significantly (p<0.01) related to bumetanide-sensitive Rb+ uptake mediated by the Ma+-K+ cotransport system. Na+ leak (bumetanide-resistant net Na+ uptake) correlated positively with blood pressure in female but not in male F2 rats. The close association between plasma triglycerides and erythrocyte Na+ content suggests that ion transport alterations might contribute to mechanisms responsible for the cosegregation of blood pressure with plasma triglycerides in HTG x Lewis F2 hybrids.
The rock agama, Laudakia caucasia Eichwald (Agamidae) is host to Plasmodium caucasica sp. n. and Saurocytozoon agamidorum sp. n. in western Pakistan. Plasmodium caucasica is characterized by very large meronts, 11-21 by 8-17 µm that produce 32-67 merozoites, which nearly fill the host erythrocyte, and smaller, ovoid to elongate gametocytes, 6-14 by 2.5-6 µm, with length by width (LW) 21-55 µm2, and L/W ratio 1.0-4.0. Host cells are usually mature erythrocytes. In Azerbaijan, P. caucasica parasitizes immature erythroid cells. Dimensions of meronts are 10-16 by 6-12 µm, and merozoite numbers are 12-44. Gametocytes are 6-14 by 3-6 µm, with LW 31-56 µm2, and L/W ratio 1.0-4.0. Saurocytozoon agamidorum sp. n. gametocytes are 6.5-13 µm in diameter, with LW 35-79 µm2, and L/W ratio 1.0-2.2. They occupy lymphocytes as host cells, which are greatly distorted by gametocyte presence and often show nuclei nearly divided into two portions, one portion at each end of the cell. Haemocystidium grahami (Shortt, 1922), redescribed from material found in L. caucasia from Azerbaijan, has rounded to elongate gametocytes, 8-19.5 by 4-8 µm, LW 60.5-102 µm2, and L/W ratio 1.0-4.5. The prominent light golden pigment granules often coalesce to nearly cover the surface of the gametocyte. The presence of P. caucasica and S. agamidorum extends the range of the two genera in saurian hosts throughout much of the southern Asia mainland.
Plasma levels of circulating platelet extracellular vesicles (PEVs) are an emerging marker of platelet activation, thrombosis, inflammation, and endothelial dysfunction. Analysis of PEVs in cord blood of preterm newborns may reflect the underlying pathology and possibly serve as a new diagnostic and prognostic tool. However, collection, preparation and analysis of cord blood samples in clinical settings is a logistically complex process. We have studied the effect of delay in sample preparation and sample freezing on the PEV analysis by flow cytometry. PEVs in the cord blood plasma were identified after double labelling with monoclonal antibodies CD36+CD41 or CD41+CD62. Both, the delay and the freezing significantly affected the count and often also fluorescence of the detected PEVs. Additionally, our pilot study utilizing fresh cord blood samples of term and preterm newborns demonstrated significantly decreased CD36 and CD62 PEV fluorescence in preterm newborns. Our data highlight the importance of pre-analytical steps in the analysis of cord blood PEVs and suggest that not only the count, but also the level of PEV fluorescence may have possible diagnostic potential.
Základním symptomem diabetes mellitus je hyperglykemie. Zvýšené kardiovaskulární riziko (KVR) u pacientů s diabetes mellitus 1. i 2. typu má však multifaktoriální etiologii. Současný negativní vliv hyperglykemie, hypertenze a hyperlipidemie na cévní systém se navzájem potencuje. Důsledná prevence kardiovaskulárních rizikových parametrů u pacientů s diabetes mellitus 2. typu (DM2T) významně snížila mortalitu a morbiditu na kardiovaskulární nemoci. Přesto zbývá „reziduální riziko“. Plné využití potenciálu statinů a jejich kombinace s ezetimibem může ještě více snížit KVR a prodloužit tak život pacientů s DM2T. Význam intervence inhibitory PCSK9 pro snížení kardiovaskulárního rizika u pacientů s diabetes mellitus je předmětem studia., The basic symptom of diabetes mellitus is hyperglycemia. However the increased cardiovascular risk in patients with both type 1 and type 2 diabetes mellitus has a multifactorial etiology. Concurrent negative effects of hyperglycemia, hypertension and hyperlipidemia on the vascular system reinforce one another. Consistent prevention of cardiovascular risk parameters in patients with type 2 diabetes mellitus (DM2T) has brought significant decline in mortality and morbidity due to cardiovascular diseases. Still there is “residual risk” remaining. The full use of the potential of statins and their combination with ezetimibe may lower the CV risk even more and extend the life of patients with DM2. The importance of an intervention by means of PCSK9 inhibitors for the cardiovascular risk reduction in patients with diabetes mellitus is the subject of study., and Milan Kvapil